LinkedIn Profile

Access BioAegis Therapeutics historical Linkedin company profile data on number of followers, employee headcount and more

Rows

Open dataset
Ticker Symbol Entity Name As Of Date Company Name Followers Employees on Linkedin Link Industry Date Added Date Updated Description Website Specialities Logo HQ.Street HQ.City HQ.State HQ.Country HQ.Postal Headcount change in past 24 months Company Name Sector Industry
private:bioaegistherapeutics 1851437 Dec 3rd, 2020 12:00AM BioAegis Therapeutics, Inc. 605 13.00 Open Biotechnology Dec 3rd, 2020 09:10AM Dec 3rd, 2020 09:10AM Commercializing Ground Breaking Discoveries in Inflammation and Infection BioAegis Therapeutics products restore plasma gelsolin, a human protein, whose important clinical role has been studied in animals and humans. Based on discoveries by Dr. Thomas Stossel and others, the body’s natural reservoir of plasma gelsolin keeps inflammation local, while its deficiency leads to inflammatory dysregulation and catastrophic consequences like multiple organ failure, shock and death. Systemic inflammation causes morbidity and mortality in a myriad of diseases including rare orphan indications and major acute and chronic diseases such as trauma, burns, renal disease and sepsis. Replacement of plasma gelsolin holds great promise for patients suffering from severe conditions with high unmet medical needs. BioAegis is developing high value, biomarker-directed treatments across a range of indications. Open Open 675 US Route 1 North Brunswick New Jersey US 08902 BioAegis Therapeutics Health Care Pharmaceuticals & Biotechnology
private:bioaegistherapeutics 1851437 Dec 2nd, 2020 12:00AM BioAegis Therapeutics, Inc. 605 13.00 Open Biotechnology Dec 2nd, 2020 11:30AM Dec 2nd, 2020 11:30AM Commercializing Ground Breaking Discoveries in Inflammation and Infection BioAegis Therapeutics products restore plasma gelsolin, a human protein, whose important clinical role has been studied in animals and humans. Based on discoveries by Dr. Thomas Stossel and others, the body’s natural reservoir of plasma gelsolin keeps inflammation local, while its deficiency leads to inflammatory dysregulation and catastrophic consequences like multiple organ failure, shock and death. Systemic inflammation causes morbidity and mortality in a myriad of diseases including rare orphan indications and major acute and chronic diseases such as trauma, burns, renal disease and sepsis. Replacement of plasma gelsolin holds great promise for patients suffering from severe conditions with high unmet medical needs. BioAegis is developing high value, biomarker-directed treatments across a range of indications. Open Open 675 US Route 1 North Brunswick New Jersey US 08902 BioAegis Therapeutics Health Care Pharmaceuticals & Biotechnology
private:bioaegistherapeutics 1851437 Dec 1st, 2020 12:00AM BioAegis Therapeutics, Inc. 605 13.00 Open Biotechnology Dec 1st, 2020 10:06AM Dec 1st, 2020 10:06AM Commercializing Ground Breaking Discoveries in Inflammation and Infection BioAegis Therapeutics products restore plasma gelsolin, a human protein, whose important clinical role has been studied in animals and humans. Based on discoveries by Dr. Thomas Stossel and others, the body’s natural reservoir of plasma gelsolin keeps inflammation local, while its deficiency leads to inflammatory dysregulation and catastrophic consequences like multiple organ failure, shock and death. Systemic inflammation causes morbidity and mortality in a myriad of diseases including rare orphan indications and major acute and chronic diseases such as trauma, burns, renal disease and sepsis. Replacement of plasma gelsolin holds great promise for patients suffering from severe conditions with high unmet medical needs. BioAegis is developing high value, biomarker-directed treatments across a range of indications. Open Open 675 US Route 1 North Brunswick New Jersey US 08902 BioAegis Therapeutics Health Care Pharmaceuticals & Biotechnology
private:bioaegistherapeutics 1851437 Nov 30th, 2020 12:00AM BioAegis Therapeutics, Inc. 605 13.00 Open Biotechnology Nov 30th, 2020 10:25AM Nov 30th, 2020 10:25AM Commercializing Ground Breaking Discoveries in Inflammation and Infection BioAegis Therapeutics products restore plasma gelsolin, a human protein, whose important clinical role has been studied in animals and humans. Based on discoveries by Dr. Thomas Stossel and others, the body’s natural reservoir of plasma gelsolin keeps inflammation local, while its deficiency leads to inflammatory dysregulation and catastrophic consequences like multiple organ failure, shock and death. Systemic inflammation causes morbidity and mortality in a myriad of diseases including rare orphan indications and major acute and chronic diseases such as trauma, burns, renal disease and sepsis. Replacement of plasma gelsolin holds great promise for patients suffering from severe conditions with high unmet medical needs. BioAegis is developing high value, biomarker-directed treatments across a range of indications. Open Open 675 US Route 1 North Brunswick New Jersey US 08902 BioAegis Therapeutics Health Care Pharmaceuticals & Biotechnology
private:bioaegistherapeutics 1851437 Nov 29th, 2020 12:00AM BioAegis Therapeutics, Inc. 605 13.00 Open Biotechnology Nov 29th, 2020 05:10PM Nov 29th, 2020 05:10PM Commercializing Ground Breaking Discoveries in Inflammation and Infection BioAegis Therapeutics products restore plasma gelsolin, a human protein, whose important clinical role has been studied in animals and humans. Based on discoveries by Dr. Thomas Stossel and others, the body’s natural reservoir of plasma gelsolin keeps inflammation local, while its deficiency leads to inflammatory dysregulation and catastrophic consequences like multiple organ failure, shock and death. Systemic inflammation causes morbidity and mortality in a myriad of diseases including rare orphan indications and major acute and chronic diseases such as trauma, burns, renal disease and sepsis. Replacement of plasma gelsolin holds great promise for patients suffering from severe conditions with high unmet medical needs. BioAegis is developing high value, biomarker-directed treatments across a range of indications. Open Open 675 US Route 1 North Brunswick New Jersey US 08902 BioAegis Therapeutics Health Care Pharmaceuticals & Biotechnology
private:bioaegistherapeutics 1851437 Nov 28th, 2020 12:00AM BioAegis Therapeutics, Inc. 604 13.00 Open Biotechnology Nov 28th, 2020 01:03PM Nov 28th, 2020 01:03PM Commercializing Ground Breaking Discoveries in Inflammation and Infection BioAegis Therapeutics products restore plasma gelsolin, a human protein, whose important clinical role has been studied in animals and humans. Based on discoveries by Dr. Thomas Stossel and others, the body’s natural reservoir of plasma gelsolin keeps inflammation local, while its deficiency leads to inflammatory dysregulation and catastrophic consequences like multiple organ failure, shock and death. Systemic inflammation causes morbidity and mortality in a myriad of diseases including rare orphan indications and major acute and chronic diseases such as trauma, burns, renal disease and sepsis. Replacement of plasma gelsolin holds great promise for patients suffering from severe conditions with high unmet medical needs. BioAegis is developing high value, biomarker-directed treatments across a range of indications. Open Open 675 US Route 1 North Brunswick New Jersey US 08902 BioAegis Therapeutics Health Care Pharmaceuticals & Biotechnology
private:bioaegistherapeutics 1851437 Nov 27th, 2020 12:00AM BioAegis Therapeutics, Inc. 602 13.00 Open Biotechnology Nov 27th, 2020 09:23AM Nov 27th, 2020 09:23AM Commercializing Ground Breaking Discoveries in Inflammation and Infection BioAegis Therapeutics products restore plasma gelsolin, a human protein, whose important clinical role has been studied in animals and humans. Based on discoveries by Dr. Thomas Stossel and others, the body’s natural reservoir of plasma gelsolin keeps inflammation local, while its deficiency leads to inflammatory dysregulation and catastrophic consequences like multiple organ failure, shock and death. Systemic inflammation causes morbidity and mortality in a myriad of diseases including rare orphan indications and major acute and chronic diseases such as trauma, burns, renal disease and sepsis. Replacement of plasma gelsolin holds great promise for patients suffering from severe conditions with high unmet medical needs. BioAegis is developing high value, biomarker-directed treatments across a range of indications. Open Open 675 US Route 1 North Brunswick New Jersey US 08902 BioAegis Therapeutics Health Care Pharmaceuticals & Biotechnology
private:bioaegistherapeutics 1851437 Nov 26th, 2020 12:00AM BioAegis Therapeutics, Inc. 602 13.00 Open Biotechnology Nov 26th, 2020 10:24AM Nov 26th, 2020 10:24AM Commercializing Ground Breaking Discoveries in Inflammation and Infection BioAegis Therapeutics products restore plasma gelsolin, a human protein, whose important clinical role has been studied in animals and humans. Based on discoveries by Dr. Thomas Stossel and others, the body’s natural reservoir of plasma gelsolin keeps inflammation local, while its deficiency leads to inflammatory dysregulation and catastrophic consequences like multiple organ failure, shock and death. Systemic inflammation causes morbidity and mortality in a myriad of diseases including rare orphan indications and major acute and chronic diseases such as trauma, burns, renal disease and sepsis. Replacement of plasma gelsolin holds great promise for patients suffering from severe conditions with high unmet medical needs. BioAegis is developing high value, biomarker-directed treatments across a range of indications. Open Open 675 US Route 1 North Brunswick New Jersey US 08902 BioAegis Therapeutics Health Care Pharmaceuticals & Biotechnology
private:bioaegistherapeutics 1851437 Nov 25th, 2020 12:00AM BioAegis Therapeutics, Inc. 601 13.00 Open Biotechnology Nov 25th, 2020 01:09PM Nov 25th, 2020 01:09PM Commercializing Ground Breaking Discoveries in Inflammation and Infection BioAegis Therapeutics products restore plasma gelsolin, a human protein, whose important clinical role has been studied in animals and humans. Based on discoveries by Dr. Thomas Stossel and others, the body’s natural reservoir of plasma gelsolin keeps inflammation local, while its deficiency leads to inflammatory dysregulation and catastrophic consequences like multiple organ failure, shock and death. Systemic inflammation causes morbidity and mortality in a myriad of diseases including rare orphan indications and major acute and chronic diseases such as trauma, burns, renal disease and sepsis. Replacement of plasma gelsolin holds great promise for patients suffering from severe conditions with high unmet medical needs. BioAegis is developing high value, biomarker-directed treatments across a range of indications. Open Open 675 US Route 1 North Brunswick New Jersey US 08902 BioAegis Therapeutics Health Care Pharmaceuticals & Biotechnology
private:bioaegistherapeutics 1851437 Nov 24th, 2020 12:00AM BioAegis Therapeutics, Inc. 600 13.00 Open Biotechnology Nov 24th, 2020 09:20AM Nov 24th, 2020 09:20AM Commercializing Ground Breaking Discoveries in Inflammation and Infection BioAegis Therapeutics products restore plasma gelsolin, a human protein, whose important clinical role has been studied in animals and humans. Based on discoveries by Dr. Thomas Stossel and others, the body’s natural reservoir of plasma gelsolin keeps inflammation local, while its deficiency leads to inflammatory dysregulation and catastrophic consequences like multiple organ failure, shock and death. Systemic inflammation causes morbidity and mortality in a myriad of diseases including rare orphan indications and major acute and chronic diseases such as trauma, burns, renal disease and sepsis. Replacement of plasma gelsolin holds great promise for patients suffering from severe conditions with high unmet medical needs. BioAegis is developing high value, biomarker-directed treatments across a range of indications. Open Open 675 US Route 1 North Brunswick New Jersey US 08902 BioAegis Therapeutics Health Care Pharmaceuticals & Biotechnology

Request a demo to view additional historical data, and much more.

Request Demo

Make fast
queries

No longer rely on engineers to access data; build and share queries with intuitive tools, and derive insights in real time.

Bookmark queries with your team

Save and share custom queries using a private bookmarking feature, accessible to your whole team.

Be first to know with alerts

Scan data points across millions of companies and receive emails when relevant metrics cross critical thresholds.

Visualize data for quick insights

Create custom keyword-based word clouds, charts, and advanced visualizations to quickly analyze the data.

Map competitor locations

Analyze competitor presence and growth over time by overlaying store locations with the Nearby Competitor feature.

Add widgets to your dashboards

Access existing maps, charts, word clouds, and other visualizations to understand your data quickly. Or build custom widgets to view data just the way you want it.